Introduction

Freeman-Sheldon Syndrome (FSS) is an uncommon birth defect,¹ characterised by specific craniofacial malformations, joint contractures, and musculoskeletal deformities. It is sometimes referred to as “whistling face syndrome” due to its distinctive puckered lips and chapped mouth. FSS presents a complex collection of symptoms with significant variability from one case to another, varying widely in terms of severity.

Proper diagnosis is fundamental, as it allows for early identification of the syndrome, timely intervention, symptom management and appropriate genetic counselling for affected families. FSS is typically inherited in an autosomal dominant manner, with mutations in the MYH3 gene being the primary cause. Understanding the genetics behind FSS not only aids in diagnosis but also offers insights into potential treatment options and prognosis for those affected by this disorder.

Clinical features and initial presentation

FSS is characterised by a diverse set of clinical features that typically present at birth or early in life. These features primarily affect the craniofacial region and the musculoskeletal system, although other complications may also arise.

Craniofacial abnormalities 

One of the hallmark signs of FSS is craniofacial abnormalities, which are often the most noticeable and defining characteristics of the syndrome.²

Microstomia (Small mouth) with puckered lips ("Whistling face")

A key feature of FSS is a small, tightly pursed mouth that creates the appearance of a "whistling face." This results from limited movement of the facial muscles and a reduced size of the oral aperture.

Deep-set eyes and a flat nasal bridge

 People with FSS often have deep-set eyes, positioned further back in the skull than usual, along with a flattened nasal bridge, resulting in a distinctive facial appearance.

Prominent forehead and other facial dysmorphisms

A high, prominent forehead, along with other facial abnormalities such as a small chin (micrognathia) and a short nose, contribute to the distinctive facial features associated with FSS.

Musculoskeletal abnormalities

Musculoskeletal abnormalities are another prominent feature of FSS, affecting both the limbs and the spine.³

Contractures of the fingers (Camptodactyly) and joints (Arthrogryposis)

Joint contractures, particularly in the fingers and hands, are common in FSS. Camptodactyly, characterised by permanently bent fingers, and arthrogryposis, involving multiple joint contractures, can significantly impact hand function and mobility.

Clubfoot (Talipes equinovarus)

Many individuals with FSS are born with clubfoot, a condition in which the feet are twisted inward and downward. This can affect walking and may require corrective surgery or orthotic intervention.

Spine abnormalities such as scoliosis

Scoliosis, a lateral curvature of the spine, is frequently observed in FSS. This condition can range from mild to severe and may require orthopaedic management to prevent further complications.

Additional features

Beyond the craniofacial and musculoskeletal features, FSS can present with additional complications that impact quality of life.

Speech and feeding difficulties

Due to craniofacial abnormalities, individuals with FSS often experience difficulties with speech and feeding. The small mouth and limited muscle movement can make it challenging to articulate words clearly and manage food intake, sometimes necessitating speech therapy or special feeding techniques.

Respiratory issues due to facial and muscle abnormalities

The restricted airway and muscle weakness associated with FSS can lead to respiratory problems, particularly during infancy and early childhood. These issues may require medical intervention, such as breathing support or surgical procedures to improve airway patency.

In addition, other developmental issues may arise during different stages of life due to FSS. These can include, but are not limited to, respiratory problems such as asthma attacks, recurrent chest infections, or pneumonia; eye problems like strabismus (squinting) or amblyopia (lazy eye); and hearing impairments such as conductive hearing loss or sensorineural hearing loss. 

Genetic testing and diagnosis

Genetic testing plays a critical role in confirming a diagnosis of FSS, providing insights into its genetic basis and inheritance patterns.⁴

Genetic dasis

Mutation in the MYH3 gene

The MYH3 gene encodes a protein crucial for proper muscle formation and function. Mutations in this gene disrupt the normal development of skeletal muscles and joints, leading to the characteristic features of FSS, including joint contractures and craniofacial abnormalities.

Autosomal dominant

FSS follows an autosomal dominant inheritance pattern, meaning that only one copy of the mutated gene is required for an individual to express the syndrome. If a parent has the syndrome, there is a 50% chance that their offspring will inherit the condition. This pattern emphasises the importance of understanding the genetic history of affected families.

Genetic testing

Genetic testing should be considered when an individual exhibits the clinical features associated with FSS. Early testing is important for infants and children, as it can guide management and treatment decisions.

Targeted gene sequencing

This test specifically analyses the MYH3 gene for known mutations associated with FSS. It is the most direct approach for confirming a diagnosis when FSS is strongly suspected based on the clinical features.

Whole exome sequencing (WES)

In cases where the diagnosis is uncertain or when additional genetic information is needed, WES can be done. This broader test examines all the protein-coding regions of the genome, which can identify mutations in MYH3 or other genes that may contribute to similar syndromes or complex phenotypes.

Interpretation of results

Interpreting the results of genetic testing is crucial for diagnosing FSS and providing appropriate guidance to the patient and their family.

Positive vs. negative results and implications

A positive result confirms MYH3 mutation and validates the FSS diagnosis, guiding clinical management and care. A negative result may indicate the need for further genetic analysis or consideration of an alternative diagnosis.

Genetic counselling for family members

Genetic counselling for families with a confirmed FSS diagnosis provides essential insights into the autosomal dominant inheritance pattern, transmission risks to future offspring, family planning, and support for understanding the syndrome, managing expectations, and addressing social and emotional challenges.

Differential diagnosis

Accurately diagnosing FSS is essential for appropriate management and treatment. While FSS shares symptoms with various other conditions, distinguishing it from similar disorders is crucial. The differential diagnosis involves comparing FSS with conditions that exhibit overlapping symptoms and applying specific diagnostic criteria to ensure accurate identification.

Conditions with overlapping symptoms

Distinction from other craniofacial syndromes

Differentiating FSS from arthrogryposis requires a detailed analysis of joint involvement and the pattern of craniofacial abnormalities. Arthrogryposis typically affects multiple joints and often presents with more severe contractures and muscle weakness throughout the body.

Distal arthrogryposis type 2A (DA2A)

DA2A typically involves specific patterns of joint deformities, primarily affecting the hands and feet. A detailed genetic evaluation and assessment of the pattern and severity of joint contractures can help differentiate DA2A from FSS.

Connective tissue disorder

Conditions like Ehlers-Danlos Syndrome (EDS) and Marfan Syndrome can present with connective tissue abnormalities and may share some features with FSS, such as skin hyperextensibility or joint laxity. However, these disorders often have additional systemic manifestations, such as cardiovascular abnormalities or hypermobility, which can help distinguish them from FSS.

Muscular disorders

Muscular dystrophies and myopathies may also exhibit overlapping features, such as muscle weakness or contractures. However, these conditions typically present with progressive muscle degeneration and specific patterns of weakness, which can help differentiate them from FSS.

Diagnostic criteria

Accurate diagnosis of Facial Skeletal Syndrome (FSS) requires identifying distinct craniofacial abnormalities, such as unusual skull shapes and facial asymmetry, along with specific patterns of joint contractures and limb deformities. Genetic testing is crucial for confirming FSS by identifying unique genetic mutations, which helps differentiate it from other similar conditions. Comparing FSS with similar syndromes highlights its unique features and aids in refining diagnostic criteria, ensuring precise identification and differentiation from other disorders.  Diagnostic  methodologies may include: 

• Facial skeletal features
• Joint and limb abnormalities
  • Genetic testing
  • Unique features of FSS
  • Establishing diagnostic criteria

Multidisciplinary evaluation

In evaluating complex medical conditions, especially those with congenital or developmental aspects, a multidisciplinary approach is essential.

Role of specialists

• Geneticists: They diagnose genetic disorders by assessing family history, conducting genetic tests, and interpreting results to identify hereditary patterns and guide targeted treatments
• Orthopaedic Surgeons: They focus on the musculoskeletal system, diagnosing bone, joint, and muscle abnormalities, planning surgical interventions, and managing long-term orthopaedic health
• Neurologists: They evaluate the nervous system to diagnose conditions affecting cognitive and motor functions, providing insights into neurological implications
• Craniofacial Specialists: They assess and address craniofacial abnormalities, such as cleft palates and craniosynostosis, coordinating surgical and therapeutic interventions to improve both appearance and function

Diagnostic imaging and other tests

Additionally, diagnostic imaging and functional assessments are crucial. For example, X-rays and MRIs offer detailed views of bone and soft tissue structures, aiding in the diagnosis of conditions like scoliosis and complex musculoskeletal issues. Functional assessments, including speech and feeding evaluations, help to understand how the condition affects oral and pharyngeal functions, while other tests assess motor skills, cognitive functions, and developmental progress. This comprehensive, team-based approach ensures an accurate diagnosis and the development of a tailored treatment plan. 

Challenges in diagnosis

Diagnosing complex medical conditions presents several challenges, including:

Variability in presentation

The severity of clinical features can vary widely, making it difficult to accurately identify and diagnose the condition. Early detection is particularly challenging in mild cases where symptoms may not be immediately apparent.

Overlapping symptoms with other disorders

There is a significant potential for misdiagnosis due to overlapping symptoms with other disorders, underscoring the need for a thorough and comprehensive evaluation.

Delays in diagnosis

Delayed diagnosis can have a profound impact on both the management of the condition and the overall prognosis, potentially leading to less effective treatment outcomes.

Summary

Early and accurate diagnosis is crucial in managing Freeman-Sheldon Syndrome, as it directly influences treatment outcomes and the patient's quality of life. Advances in genetic testing have significantly improved diagnostic accuracy, enabling earlier detection and more precise identification of the condition. As these technologies continue to evolve, they hold promise for further enhancing diagnostic capabilities and guiding personalised treatment approaches. Looking ahead, ongoing research and innovation in the diagnosis and management of Freeman-Sheldon Syndrome will be essential in improving patient care and outcomes, ensuring that individuals receive the most effective interventions as early as possible.